Back to search

Article

Statin-dye conjugates for selective targeting of <i>KRAS</i> mutant cancer cells

2025-06-06

Abstract excerpt

<h4>ABSTRACT</h4> Over 90% of pancreatic ductal adenocarcinoma (PDAC) patients involve KRAS mutations ( KRAS MUT ), for which current treatment options are limited. Statins, commonly used to lower cholesterol, have demonstrated certain selective toxicity towards KRAS -transformed cells, prompting the question of whether statins could achieve selective uptake specifically in KRAS MUT cells. To investigate this...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9bf3ad81-6eb3-51a0-981d-c974a7ee53a6
DOI
10.1101/2025.06.03.657329
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Statin-dye conjugates for selective targeting of <i>KRAS</i> mutant cancer cellsDOI 10.1101/2025.06.03.657329
Select a neighboring publication to make it the new centre.